Monthly Archives: September 2023

Class 4 Medicines Defect Information: Duraphat 5000ppm Fluoride Toothpaste (51g) Colgate-Palmolive (U.K.) Limited Drug alert number: EL (23)A/35 Date issued: 7 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Duraphat 5000ppm Fluoride Toothpaste (51g) Colgate-Palmolive (U.K.) Limited Company name: Colgate-Palmolive (U.K.) Limited Product [...]

The post Class 4 Medicines Defect Information: Duraphat 5000ppm Fluoride Toothpaste (51g) Colgate-Palmolive (U.K.) Limited appeared first on Community Pharmacy England.

Peter Aldous MP has secured a Westminster Hall Debate on the Future of Community Pharmacies, on Thursday 14th September at 3pm. This is very timely as it will coincide with the launch of the Vision for community pharmacy on the 19th September, which is being developed by The King’s Fund and Nuffield Trust. This will [...]

The post MPs to hold parliamentary debate on the future of community pharmacies appeared first on Community Pharmacy England.

UPDATE: 10th-12th September The UK Health Security Agency (UKHSA) and the Met Office have updated the heat-health alerts across the following regions: East of England, London, and the South East: The amber alert (enhanced hot weather response) remains in place until 9am on 12th September. Yorkshire and the Humber, East Midlands, West Midlands, and the [...]

The post Heat-Health Alert (September 2023): resources for pharmacies appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/34 Date issued: 5 September 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Evorel Sequi (Theramex HQ UK Ltd) PL 49105/0010 SNOMED Code: 3217311000001104 Batch Number Expiry Date Pack Size First Distributed 6029403 July 2024 8 patches 13th June 2023 Active Pharmaceutical [...]

The post Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) appeared first on Community Pharmacy England.

The Government has updated their guidance on the HRT PPC.  Some of the key changes include:  Clarifying that listed HRT medicines, regardless of the clinical reason for prescribing, must be on a separate prescription to other non-HRT items, on both paper and electronic prescriptions.  Explaining the scope of the HRT PPCs, highlighting that the PPC [...]

The post HRT PPC: DHSC Guidance appeared first on Community Pharmacy England.